IQOS, the flagship heated tobacco product developed by Philip Morris International (PMI), represents one of the most significant shifts in the history of the tobacco industry. As public health campaigns, mounting scientific evidence, and governmental regulations targeted the dangers of smoking, the global tobacco industry faced declining smoking rates and increasing pressure to find alternatives to traditional cigarettes.
Philip Morris recognized this shift and positioned itself to lead the transition from combustible tobacco products to reduced-risk products (RRPs). IQOS, which heats tobacco rather than burning it, was developed as a solution to provide smokers with an alternative that delivers the taste and experience of cigarettes without producing harmful smoke. This article explores the development of IQOS, its global expansion, and its impact on both the tobacco industry and the future of nicotine consumption.
1. The Need for Innovation: The Early Years of Research and Development
The story of IQOS began in the early 2000s when Philip Morris International (PMI) first realized the need to invest in alternatives to traditional cigarettes. Public health studies increasingly pointed to the severe health risks of smoking, including lung cancer, heart disease, and respiratory illnesses. Governments worldwide began implementing stricter regulations on cigarette sales, advertising, and public smoking, and consumers were becoming more aware of the dangers of smoking.
a. Early Research into Heated Tobacco: Recognizing these challenges, PMI set out to create products that would reduce the harmful effects of smoking without eliminating the nicotine experience that smokers sought. The goal was to develop a product that would appeal to smokers who wanted to quit or reduce their consumption of cigarettes but still desired the ritual, flavor, and satisfaction of tobacco use.
While PMI had been experimenting with heated tobacco technologies for years, it wasn’t until the mid-2000s that the company’s research and development efforts began to bear fruit. Heated tobacco, unlike traditional cigarettes, does not involve the combustion of tobacco. Instead, the tobacco is heated to a lower temperature (around 350°C), which releases nicotine and tobacco flavors without producing the harmful chemicals created by combustion.
b. The Vision for a Smoke-Free Future: PMI’s CEO at the time, André Calantzopoulos, outlined the company’s vision of a “smoke-free future.” He emphasized that while the best decision for smokers would be to quit, PMI aimed to offer a reduced-risk product that could significantly lower the harm associated with tobacco use. This vision paved the way for IQOS, which would become the centerpiece of PMI’s harm reduction strategy.
2. The Launch of IQOS: A Game-Changer in the Tobacco Industry
a. The Birth of IQOS: In 2014, after years of development and millions of dollars in research, PMI launched IQOS, a brand-new product that heats specially designed tobacco sticks (called HeatSticks or Heets in some markets) to produce vapor rather than smoke. IQOS was first introduced in test markets, including Nagoya, Japan, and Milan, Italy, where the product quickly gained traction.
The name IQOS is believed to stand for “I Quit Original Smoking,” though PMI has never officially confirmed this. The product was designed to be sleek and modern, targeting adult smokers who were looking for an alternative to traditional cigarettes without the stigma associated with e-cigarettes or nicotine patches.
The key selling point of IQOS was that it offered the taste and experience of smoking without combustion, which is responsible for the vast majority of harmful chemicals found in cigarette smoke. PMI promoted IQOS as a product that significantly reduced the risk of smoking-related diseases because it did not burn tobacco, instead heating it at a much lower temperature.
b. Expansion into New Markets: Following the success of IQOS in test markets, PMI rapidly expanded the product’s availability to more countries. Japan, in particular, became one of the most important markets for IQOS, with sales of heated tobacco products quickly overtaking traditional cigarettes. By 2016, IQOS had been launched in more than 20 countries, including key markets in Europe, Asia, and Latin America.
IQOS’s rapid expansion was fueled by PMI’s massive investment in marketing and infrastructure. PMI built IQOS-branded stores and kiosks in major cities, offering smokers a hands-on experience with the product and personalized customer service. These stores helped create a sense of community around IQOS, positioning it not just as a product, but as part of a new, healthier lifestyle for smokers.
3. The Science Behind IQOS: Harm Reduction and Regulatory Approval
One of the central pillars of PMI’s marketing strategy for IQOS is its claim that the product is a reduced-risk alternative to traditional cigarettes. PMI invested heavily in scientific research to support this claim, conducting numerous studies to prove that IQOS significantly reduces the levels of harmful chemicals that users are exposed to compared to smoking.
a. Health Claims and Scientific Studies: According to PMI’s research, IQOS produces 95% fewer harmful chemicals compared to conventional cigarette smoke, particularly the chemicals known to cause cancer, respiratory diseases, and cardiovascular problems. These claims were backed by independent studies from regulatory bodies in some countries, though the debate over the long-term health impact of IQOS remains ongoing.
Despite the reduced exposure to harmful chemicals, public health experts remain cautious, emphasizing that IQOS is not without risks. While it may be less harmful than smoking, it still delivers nicotine, which is addictive and can have negative health effects, particularly on cardiovascular health. Moreover, some critics argue that the long-term effects of heated tobacco products are still unknown, as IQOS has only been on the market for a relatively short time.
b. Regulatory Approvals and U.S. Entry: A major milestone for IQOS came in 2019 when the U.S. Food and Drug Administration (FDA) granted PMI permission to sell IQOS in the United States under its modified risk tobacco product (MRTP) pathway. The FDA determined that IQOS significantly reduced the production of harmful chemicals compared to cigarettes, though the agency stopped short of labeling the product as “safe.”
PMI, through its U.S. partner Altria Group, began selling IQOS in select U.S. markets in 2020, with plans to expand its availability. The FDA’s decision marked a significant victory for PMI, as the U.S. is one of the largest and most heavily regulated tobacco markets in the world.
4. Marketing IQOS: A New Approach to Consumer Engagement
One of the challenges PMI faced with IQOS was how to market the product in a way that complied with strict tobacco advertising regulations while also appealing to a new generation of smokers. Unlike cigarettes, which have been advertised through bold imagery and slogans, IQOS needed a modern, tech-driven approach that emphasized innovation, harm reduction, and lifestyle.
a. Tech-Savvy Branding: IQOS was marketed as a premium, tech-savvy product for modern smokers. Its sleek design, advanced heating technology, and accompanying smartphone app positioned it as a product for consumers who valued both innovation and health-consciousness. IQOS kiosks and stores offered consumers the chance to try the product firsthand, with staff providing personalized guidance on how to use the device and integrate it into their daily lives.
PMI focused on experiential marketing by creating IQOS lounges and pop-up stores in urban centers, where potential customers could learn about the science behind the product, interact with it, and see it as part of a healthier lifestyle. This strategy helped IQOS differentiate itself from traditional cigarettes, which were becoming increasingly stigmatized.
b. Navigating Advertising Restrictions: Like all tobacco products, IQOS is subject to strict advertising restrictions in many countries. PMI adapted its marketing to comply with these regulations by focusing on digital marketing, social media, and word-of-mouth marketing. Influencers and lifestyle bloggers were employed to promote IQOS as part of a modern, health-conscious lifestyle.
The emphasis on science and harm reduction also became a central theme in IQOS marketing, with PMI creating detailed websites that showcased the product’s benefits, including scientific studies, testimonials, and comparisons to traditional cigarettes. This digital-first approach allowed PMI to reach younger adult consumers who were already familiar with e-cigarettes and other alternative nicotine products.
5. The Global Impact of IQOS: Changing the Tobacco Landscape
IQOS has become a central part of PMI’s vision for a smoke-free future, and its impact on the global tobacco landscape has been profound. By the end of 2023, over 30 million people worldwide had switched from smoking to IQOS, making it one of the most successful reduced-risk products in the tobacco industry.
a. IQOS vs. E-Cigarettes: While e-cigarettes such as Juul and Vuse have also made significant strides in the reduced-risk product category, IQOS offers a different experience by using real tobacco rather than nicotine liquids. This distinction has helped PMI target consumers who prefer the taste and ritual of smoking but are looking for a less harmful alternative.
Japan, in particular, has become a major market for IQOS, where heated tobacco products have outsold traditional cigarettes in recent years. IQOS’s success in Japan has been closely watched by other markets, particularly in Asia, where smoking rates remain high and consumers are looking for alternatives.
b. Regulatory and Public Health Challenges: Despite its success, IQOS faces ongoing challenges. Some public health advocates remain skeptical about PMI’s intentions, arguing that IQOS may be part of a broader strategy to maintain nicotine addiction rather than eliminate it. Others are concerned that IQOS could attract non-smokers, particularly younger consumers, who might be drawn to the product’s modern design and marketing.
Additionally, regulatory challenges continue to evolve, with governments around the world debating how to best regulate heated tobacco products. While some countries have embraced IQOS as a harm-reduction tool, others remain cautious about allowing tobacco companies to market new nicotine products.
IQOS and the Future of Tobacco
IQOS represents a monumental shift in the way the tobacco industry approaches product innovation, harm reduction, and consumer engagement. By focusing on scientific research, modern technology, and a reduced-risk narrative, PMI has positioned IQOS as the cornerstone of its strategy for a smoke-free future.
As the global tobacco industry continues to evolve, IQOS stands at the forefront of the movement toward less harmful alternatives to smoking. Its success has already reshaped the market, offering a glimpse into a future where traditional cigarettes may one day be replaced by heated tobacco and other reduced-risk products. For PMI, IQOS is more than just a product—it is the company’s answer to the growing demand for safer ways to consume nicotine in a world that increasingly seeks to move beyond smoking.